May 20, 2021
Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day).
AptameX delivers sensitivity of 77% (95% CI: 75.94 - 79.24) at a high industry CT score of 28.3, which is comparable to current lateral flow rapid tests.
Moving to complete product registration in Indonesia and progressing to securing a CE mark in Europe with a view to approvals and sales in Q3 2021.
ZURICH, SWITZERLAND - EQS Newswire - 20 May 2021 - Achiko AG (SWX:ACHI, ISIN CH0522213468) completed production of the first 1,000 AptameX test kits and has commenced shipment to Indonesia. The Company also announces favourable preliminary Covid-19 diagnostic testing results at a high CT score; even at low viral loads, AptameX proves to be highly sensitive.
Achiko AG / Key word(s): Preliminary Results
Achiko AG: Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads
20-May-2021
The issuer is solely responsible for the content of this announcement. Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads - Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day). - AptameX delivers sensitivity of 77% (95% CI: 75.94 - 79.24) at a high industry CT score of 28.3, which is comparable to current lateral flow rapid tests.
Novel diagnostic test for COVID-19 by Achiko enters Indonesia
Novel diagnostic test for COVID-19 by Achiko enters Indonesia 30 April 2021 | News
Source: achiko
Swiss firm Achiko AG s joint venture partner PT Indonesia Farma Medis (IFM) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX.
This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the production and sales of the product in Indonesia. Achiko has subsequently commenced product registration with its partners with a view to a mid-year commercial product availability.
Achiko AG: Achiko s Joint Venture Partner Obtains A Distribution Certificate for Aptamex, A Novel Diagnostic Test for Covid-19 In Indonesia, And Commences Product Registration
Achiko subsequently commenced product registration with its partners with a view to mid-year commercial product availability
Achiko to generate revenues on a 50% holding of the joint venture and a 10% licensing fee from gross sales
ZURICH, SWITZERLAND / ACCESSWIRE / April 29, 2021 / Achiko AG s (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis ( IFM ) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX.
This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the production and sales of the product in Indonesia. Achiko has subsequently comm
Share:
Achiko AG s joint venture partner PT Indonesia Farma Medis (IFM) obtains medical device distribution certificate
Achiko subsequently commenced product registration with its partners with a view to mid-year commercial product availability
Achiko to generate revenues on a 50% holding of the joint venture and a 10% licensing fee from gross sales
ZURICH, SWITZERLAND / ACCESSWIRE / April 29, 2021 /Achiko AG s (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis ( IFM ) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX.
This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the production and sales of the product in Indonesia. Achiko has subsequently commenced product registration with its partners with a view